Sophie Joubert-Chateau
IMRB, AfterROSC Network, 7 Avenue Du Général De Gaulle
Maisons-les-soulaines, 94700, France
Maisons-les-soulaines, 94700, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Investigation of fingolimod-induced lymphocyte sequestration on inflammatory response and neurological damages after cardiac arrest.
Journal: Intensive care medicine experimental
Published: April 26, 2024
High-Mobility Group Box 1-Signaling Inhibition With Glycyrrhizin Prevents Cerebral T-Cell Infiltration After Cardiac Arrest.
Journal: Journal of the American Heart Association
Published: February 03, 2023
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.
Journal: Nature communications
Published: April 14, 2022
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast.
Journal: Journal of hematology & oncology
Published: July 15, 2021
Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials.
Journal: Translational oncology
Published: March 08, 2021
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
Journal: Breast cancer research : BCR
Published: October 05, 2020
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer.
Journal: Cancer research
Published: August 17, 2020
Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Journal: Breast cancer research : BCR
Published: February 02, 2020
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
Journal: Nature communications
Published: December 06, 2019
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 06, 2019
Last Updated: 09/26/2026